IFF vs SYRE · P/E 24, rev $3.86B vs $7.60B cap
International Flavors & Fragrances Inc (IFF) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
International Flavors & Fragrances Inc (IFF) is a specialty chemicals company listed on NYSE.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported IFF revenue for 2026-06-30 was $3.86B. Net income was $219.0M. Revenue was up 40.8% from 2026-03-31 to 2026-06-30. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
IFF currently screens at market cap $19.42B and trailing P/E 23.5. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the IFF and SYRE stock pages for the full models.
Not investment advice.